Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Human Metabolome Technologies Inc stock Dividend Yield % is close to 5-year high.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.
For more information regarding to dividend, please check our Dividend Page.
* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.
Human Metabolome Technologies (TSE:6090) Dividends per Share Explanation
1. Dividend Payout Ratio measures the percentage of the company's earnings paid out as dividends.
Human Metabolome Technologies's Dividend Payout Ratio for the quarter that ended in Dec. 2025 is calculated as
During the past 12 years, the highest Dividend Payout Ratio of Human Metabolome Technologies was 0.40. The lowest was 0.21. And the median was 0.30.
2. Dividend Yield % measures how much a company pays out in dividends each year relative to its share price.
Human Metabolome Technologies Recent Full-Year* Dividend History
Amount
Ex-date
Record Date
Pay Date
Type
Frequency
Forex Rate
JPY 18.000000
2026-06-29
2026-06-30
0000-00-00
Cash Dividend
semi-annually
JPY:JPY 1.000000
* GuruFocus has an internal rule that if the most recent dividend payment frequency is at least 4 times a year, then the full year will be calculated according to the frequency of payment or the one-year time frame, whichever is stricter.
* GuruFocus converts dividend currency to local traded share price currency in order to calculate dividend yield. Please refer to the last column "Forex Rate" in the above table.
Human Metabolome Technologies's Dividend Yield (%) for Today is calculated as
Current Share Price is 円594.00.
Human Metabolome Technologies's Dividends per Share for the trailing twelve months (TTM) ended in Today is 円18.
During the past 12 years, the highest Dividend Yield of Human Metabolome Technologies was 3.08%. The lowest was 1.32%. And the median was 2.11%.
Good Sign:
Human Metabolome Technologies Inc stock Dividend Yield % is close to 5-year high.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Human Metabolome Technologies Dividends per Share Related Terms
Human Metabolome Technologies Dividends per Share Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Human Metabolome Technologies Dividends per Share Chart
TSE:6090 vs TMO, DHR, IDXX: Dividends per Share Comparison
For the Diagnostics & Research subindustry, Human Metabolome Technologies's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Human Metabolome Technologies Dividend Yield % vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Human Metabolome Technologies's Dividend Yield % distribution charts can be found below:
* The bar in red indicates where Human Metabolome Technologies's Dividend Yield % falls into.
Human Metabolome Technologies (TSE:6090) has a Dividends per Share of 円15.00 as of Dec. 2025. Dividends per share represents the per-share amount paid as dividends. View historical data on Human Metabolome Technologies and its competitors.
Is Human Metabolome Technologies' Dividends per Share too high?
Human Metabolome Technologies' current Dividends per Share is 円15.00. Overall, Human Metabolome Technologies has a GF Score™ of 60/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Human Metabolome Technologies' Dividends per Share compare to TMO and DHR?
Human Metabolome Technologies' Dividends per Share of 円15.00 can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Dividends per Share for a Medical Diagnostics & Research company?
A good Dividends per Share depends on the Medical Diagnostics & Research industry context. However, Dividends per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Dividends per Share mean?
A high Dividends per Share can signal that a stock is expensive relative to its fundamentals. Dividends per share represents the per-share amount paid as dividends. View historical data on Human Metabolome Technologies and its competitors. Human Metabolome Technologies's current Dividends per Share is 円15.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Human Metabolome Technologies stock overvalued right now?
Based on GuruFocus' analysis, Human Metabolome Technologies (TSE:6090) is currently considered Modestly Overvalued. The stock's GF Value™ is 円531.03, compared to a current price of 円594.00 — trading 11.9% above its estimated fair value. The current Dividends per Share is 円15.00. Human Metabolome Technologies' overall GF Score™ is 60/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Dividends per Share calculated?
Dividends per Share is calculated from a company's financial statements. For Human Metabolome Technologies (TSE:6090), the current Dividends per Share is 円15.00 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Human Metabolome Technologies (TSE:6090) Overvalued in 2026?
Based on GuruFocus' analysis, Human Metabolome Technologies stock appears to be overvalued.
The current stock price of 円594.00 is trading 11.9% above its estimated GF Value™ of 円531.03.
GuruFocus considers Human Metabolome Technologies to be Modestly Overvalued.
Key valuation signals for TSE:6090:
Dividends per Share: 円15.00
GF Value™: 円531.03 vs. price of 円594.00 (11.9% above fair value)
No single metric tells the full story. See the TSE:6090 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Human Metabolome Technologies Business Description
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:6090 has been successfully added to your 
